OPTIMIZE Study to Examine Impact of Psilocybin on Depression
The OPTIMIZE Study will explore innovative methods to amplify the effects of psilocybin on depression and anxiety through the co-administration of non-invasive vagus nerve stimulation.
Donate
The OPTIMIZE Study will explore innovative methods to amplify the effects of psilocybin on depression and anxiety through the co-administration of non-invasive vagus nerve stimulation.
Join us for an enlightening talk by neuroscientist and the pioneer of consciousness research Christof Koch, PhD, as he explores transformative experiences like mystical encounters, near-death experiences, and psychedelic journeys.
(CNN) For a good number of people antidepressants have been a blessing, at least at the beginning of treatment, but for up to a third of depressed patients, antidepressants fail to work at all, said Dr. Charles Raison.
In this Learning Lab, Dr. Tracy Balboni and Dr. Michael Balboni discussed the most recent research showing how spirituality is important in patient care and holds the promise of reinvigorating how flourishing communities care for the sick.
(Newsweek) Millions of Americans struggling with depression could benefit from the active ingredient in magic mushrooms, new research suggests. However, approval of such treatments will depend on the U.S. Food and Drug Administration (FDA).